Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis

Virus Genes

Volumn 13, Issue 1, 1996, Pages 69-81

  Janini, Luiz M ^a,c   Pieniazek, Danuta ^a,e   Peralta, Jose M ^c   Schechter, Mauro ^c   Tanuri, Amilcar ^c   Vicente, Ana C P ^d   Dela Torre, Nick ^a   Pieniazek, Norman J ^b   Luo, Chi Cheng ^a   Kalish, Marcia L ^a   Schochetman, Gerald ^a   Rayfield, Mark A ^a  

^a National Center for HIV STD and TB Prevention   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Brazil; Dual infection; HIV 1; Protease gene; RFLP

Indexed keywords

ENDONUCLEASE; ETHIDIUM BROMIDE; GAG PROTEIN; PROTEINASE; VIRUS DNA;

ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA TEMPLATE; ELECTROPHORETIC MOBILITY; GENE AMPLIFICATION; GENETIC EPIDEMIOLOGY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOTOPE LABELING; LYMPHOCYTE; METHODOLOGY; MIXED INFECTION; MONONUCLEAR CELL; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROVIRUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING TEST; VIRUS CULTURE;

ADULT; BASE SEQUENCE; DNA, VIRAL; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE HOMOLOGY, NUCLEIC ACID;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10344222183     PISSN: 09208569     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00576981     Document Type: Article

References (42)

1. Alizon M., Wain-Hobson S., Montagnier L., and Sonigo P., Cell 46, 63-74, 1986.
2. Goodenow M., Huet T., Saurin W., Kwok S., Sninsky J., and Wain-Hobson S., J Acquired Immune Defic Syndr 2, 344-352, 1989.
3. Simmonds P., Balfe P., Ludlam C.A., Bishop J.O., and Leigh Brown A.J., J Virol 64, 5840-5850, 1990.
4. Meyers G., Rabson A.B., Berzofsky J.A., Smith T.F., and Wong-Staal F, (ed). Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, New Mexico, 1994.
5. Cohen J., Science 264, 1839, 1994.
6. Kliks S.C., Shioda T., Haigwood N.L., and Levy J.A., Proc Natl Acad Sci USA 90, 11518-11522, 1993.
7. Moore J. and Anderson R., Nature 372, 313-314, 1994.
8. Rey F., Salaun D, Lesbordes J.L., Gadelle S., Ollivier-Henry F., Barre-Sinoussi F., Chermann J.C., and Georges A.J., Lancet ii, 1391-1392, 1986.
9. Evans L.A., Odehouri K., Thomson-Honnebier G., Barboza A., Moreau J., Seto D., Legg H., Cheng-Mayer C., and Levy J.A., Lancet ii, 1389-1391, 1988.
10. Rayfield M., De Cock K., Heyward W., Goldstein L., Krebs J., Kwock S., Lee S., McCormick J., Moreau J.M., Odehouri K., Schochetman G., Sinski J., and Ou C.Y., J Infect Dis 158, 1170-1176, 1988.
11. George J.R., Ou C.U., Parekh B., Brattegaard K., Brown V., Boateng E., and de Cock K.M., Lancet 340, 337-339, 1992.
12. Peeters M., Gershy-Damet G.M., Fransen K., Koffi K., Coulibaly M., Delaporte E., Piot P., and van der Groen G., Lancet 340, 339-340, 1992.
13. Pieniazek D., Peralta J.M., Ferreira J.A., Krebs J.W., Owen S.M., Sion F.S., Filho C.F.R., Sereno A.B., de Sa C.A., Weniger B.G., Heyward W.L., Ou C.Y., Pieniazek N.J., Schochetman G., and Rayfield M., AIDS 5, 1293-1299, 1991.
14. !4. Grez M., Dietrich U., Balfe P., von Briesen H., Maniar J.K., Mahambre G., Delwatr E.L., Mullins J.I., and Rubsamen-Waigmenn H., J Virol 68, 2161-2168, 1994.
15. Sala M., Zambruno G., Vartanian J.-P., Marconi A., Bertazzoni U., and Wain-Hobson S., J Virol 68, 5280-5283, 1994.
16. Kellam P. and Larder B.A., J Virol 69, 669-674, 1995.
17. Poss M., Martin H.L., Kreiss J.K., Granville L., Chohan B., Nyange P., Mandaliya K., and Overbaugh J., J Virol 69, 8118-8122, 1995.
18. Zhu T., Wang N., Carr A., Wolinsky S., and Ho D., J Virol 69, 1324-1327, 1995.
19. Diaz R.S., Sabino B.C., Mayer A., Mosley J.W., Bush M.P., and the Transfusion Safety Study Group, J Virol 69, 3273-3281, 1995.
20. Li W.W., Tanimura M., and Sharp P.M., Mol Biol Evol 5, 311-330, 1988.
21. Sabino E.C., Shpaer E.G., Morgado M.G., Korber B.T.M., Diaz R.S., Bongertz V., Cavalcante S., Galvao-Castro B., Mullins J.I., and Mayer A., J Virol 68, 6340-6346, 1994.
22. Robertson D.L., Scharp P.M., McCutchan F.E., and Hahn B.H., Nature 374, 124-126, 1995.
23. Robertson D.L., Hahn B.H., and Sharp P.M., J Mol Evol 40, 249-259, 1995.
24. Leitner T., Escanilla D., Marquina S., Wahlberg J., Brostrom C., Hansson H.B., Uhlen M., and Albert J., Virology 209, 136-146, 1995.
25. Gao F., Yue L., Robertson D.L., Hill S.C., Hui H., Biggar R.J., Neequaye A.E., Whelan T.M., Ho D.D., Shaw G.M., Sharp P.M., and Hahn B.H., J Virol 68, 7433-7447, 1994.
26. Gao F., Yue L., White A.T., Pappas P.G., Barchue J., Hanson A.P., Greene B.M., Sharo P.M., Shaw G.M., and Hahn B.H., Nature 358, 495-499, 1992.
27. Artenstein A.W., VanCott T.C., Mascola J.R., Carr J.C., Hegerich P.A., Gaywee J., Sanders-Buell E., Robb M.L., Dayhoff D.E., Thitivichianlert S., Nitayaphan S., McNeil J.G., Birx D.L., Michael R.A., Burke D.S., and McCutchan F.E., J Infect Dis 171, 805-810, 1995.
28. Schechter M., Zajdenverg R., Machado L.L., Pinto M.E., Lima L.A.A.L., and Perez M.A., J Acquired Immune Defic Syndr 7, 163-168, 1994.
29. Potts E.K., Kalish M.L., Lott T., Orloff G., Luo C.C., Bernard M.A., Alves C.B., Badaro R., Suleiman J., Ferreira O., Schochetman G., Johnson, Jr. W.D., Ou C.Y., Ho J.L., and the Brazilian Collaborative AIDS Research Group, AIDS 7, 1191-1197, 1993.
30. Feorino P.M., Kalyanaraman V.S., Haverkos H.W., Cabradilla C.D., Warfield D.T., Jaffe H.W., and Harrison A.K., Science 225, 68-72, 1984.
31. Ou C.Y., Moore J.L., and Schochetman G., Biotechniques 10, 442-444, 1991.
32. Cano R.J., Poinar H.N., Pieniazek N.J., Acra A., and Poinar Jr. G.O., Nature 363, 536-538, 1993.
33. Ou C.Y., Ciesielski C.A., Myers G., Bandea C.I., Luo C.C., Korber B., Mullins J., Schochetman G., Berkelman R.L., Economou A.N., Witte J., Furman L.J., Satten G.A., MacInnes K.A., Curran J.W., Jaffe H.W., Laboratory Investigation Group, and Epidemiologic Investigation Group, Science 256, 1165-1171, 1992.
34. Higgins D.G. and Sharp P.M., Comput Appl Biosci 5, 151-153, 1989.
35. GDE version 2.2 program, Developed at the University of Illinois for the Ribosomal Data project. Available from the University of Illinois.
36. Larsen N., Olsen G.J., Maidak B.N., McCaughey M.J., Overbeek R., Macke T.J., Marsh T.L., and Woese C.R., Nucleic Acids Res 21, 3021-3023, 1993.
37. Ramos A., Tanuri A., Janini L.M., Pinto M., Schechter M., Peralta M., Bandea C., Schochetman G., Rayfield M., and Pieniazek D., HIV-1 infections in Brazil: single, duals and recombinants. Abstract. 96th ASM General Meeting, New Orleans, LA, May 19-23, 1996, #3456.
38. Louwagie J., Delwart E.L., Mullins J.I., McCutchan F.E., Eddy G., and Burke D.S., AIDS Res Hum Retroviruses 10, 561-567, 1994.
39. Morgado M.G., Sabino E.S., Shpaer E.G., Bongertz V., Brigido L., Guimaraes, M.D.C., Castilho E.A., Galvao-Castro B., Mullins J.I., Hendry R.M., and Mayer A., AIDS Res Hum Retroviruses 10, 569-576, 1994.
40. WHO network for HIV isolation and characterization, AIDS Res Hum Retroviruses 10, 1327-1343, 1994.
41. Ellenberger D.L., Luo C.-C., Pieniazek D., Maurice C., Nkengasong J., Janini L.M., Ramos A., Coulibaly I.M., Wiktor S.Z., Greenberg A.E., Schochetman G., and Rayfield M., Analysis of genetic diversity of HIV-1 in Cote d'Ivoire using restriction fragment length polymorphism (RFLP) analyses. Abstract. 11th International Conference on AIDS, Vancouver, Canada, July 7-11, 1996, #A2065.
42. Pieniazek D., Janini L.M., Ramos A., Tanuri A., Schechter M., Peralta J.M., Vicente A.C.P., Pieniazek N.J., Schochetman G., and Rayfield M.A., Emerging Infectious Diseases 1, 86-88, 1995.